Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Wohl

Showing results (71-80 of 185) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|November 17, 2010
Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjectsGeorge J Hanna, Jacob Lalezari, James A Hellinger, et al.
ERJ Open Research|November 22, 2022
COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelinesDavid A Wohl, Aprille A Espinueva, Lauren Dau, et al.
The New England Journal of Medicine|April 11, 2019
Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus DiseaseWilliam A Fischer, Ian Crozier, Daniel G Bausch, et al.
AIDS and Behavior|November 3, 2010
Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trialDavid A Wohl, Anna Scheyett, Carol E Golin, et al.
BMC Public Health|December 11, 2014
Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentryDanielle F Haley, Carol E Golin, Claire E Farel, et al.
HIV Medicine|March 15, 2023
Why we need to re-define long-term success for people living with HIVMaria J Fuster-RuizdeApodaca, David A Wohl, Mario Cascio, et al.
HIV Medicine|March 15, 2023
Long-term success for people living with HIV: A framework to guide practiceJeffrey V Lazarus, David A Wohl, Mario Cascio, et al.
AIDS (London, England)|November 21, 2007
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIVGrace A McComsey, Michelle A Kendall, Pablo Tebas, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|November 21, 2007
Incarceration and risky sexual partnerships in a southern US cityMaria R Khan, David A Wohl, Sharon S Weir, et al.
BMJ Public Health|August 18, 2025
Research protocol design and implementation of a hybrid no-touch and low-touch prospective observational study during the COVID-19 public health emergency: the VISION studyBecky Straub, Katie R Mollan, Jessica R Keys, et al.
Pageof 19

Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|November 17, 2010
Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjectsGeorge J Hanna, Jacob Lalezari, James A Hellinger, et al.
ERJ Open Research|November 22, 2022
COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelinesDavid A Wohl, Aprille A Espinueva, Lauren Dau, et al.
The New England Journal of Medicine|April 11, 2019
Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus DiseaseWilliam A Fischer, Ian Crozier, Daniel G Bausch, et al.
AIDS and Behavior|November 3, 2010
Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trialDavid A Wohl, Anna Scheyett, Carol E Golin, et al.
BMC Public Health|December 11, 2014
Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentryDanielle F Haley, Carol E Golin, Claire E Farel, et al.
HIV Medicine|March 15, 2023
Why we need to re-define long-term success for people living with HIVMaria J Fuster-RuizdeApodaca, David A Wohl, Mario Cascio, et al.
HIV Medicine|March 15, 2023
Long-term success for people living with HIV: A framework to guide practiceJeffrey V Lazarus, David A Wohl, Mario Cascio, et al.
AIDS (London, England)|November 21, 2007
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIVGrace A McComsey, Michelle A Kendall, Pablo Tebas, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|November 21, 2007
Incarceration and risky sexual partnerships in a southern US cityMaria R Khan, David A Wohl, Sharon S Weir, et al.
BMJ Public Health|August 18, 2025
Research protocol design and implementation of a hybrid no-touch and low-touch prospective observational study during the COVID-19 public health emergency: the VISION studyBecky Straub, Katie R Mollan, Jessica R Keys, et al.
Pageof 19